Navigation Links
GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009.
Date:11/24/2008

WHEAT RIDGE, Colo., Nov. 24 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR.PK), announces it will soon begin offering its Real Time PCR test for Johne's disease through its Wheat Ridge, Colo. laboratory.

GeneThera is set to begin offering its Johne's disease testing service as soon as January of 2009. According to GeneThera Chairman, Dr. Tony Milici MD, Ph.D., "We expect to be offering our real time PCR test for Johne's disease, called HerdGuard(TM) by the first of the year on a commercial level. We are already receiving inquiries from several companies as to the availability of the service."

The company states that its PCR test is much more accurate and timely than what is commonly available today. There are other PCR tests available, but what makes GeneThera's service different is exactly that... service. According to the company; "the other PCR tests that are available require the purchase of a test kit from one supplier, and then forwarding the collected samples to a completely different company for analyzing. In other words, the customer has to collect the samples (usually fecal) and send the collected samples to a separate approved laboratory for actual testing. This means the customer is responsible for finding the lab, negotiating the cost of the testing, shipping, and retrieving the results. GeneThera's service is all inclusive. Using their trademarked Field Collection System (FCS(TM)), the client collects the sample (blood, milk, fecal, or colostrum), and then returns them to GeneThera's lab for testing and reporting of the results. The results will be available to customers via a secured web page on GeneThera's website. Everything is included in the price from GeneThera. Pricing is expected to be between $25 and $32 per test, and results are typically available within 24-48 hours of receipt of the samples."

According to a recent study, the infected rate of dairy ca
'/>"/>

SOURCE GeneThera, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
2. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
3. Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
4. Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders
5. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
6. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
9. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
10. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
11. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013   Voices Against ... finding a cure for brain cancer, today announced that ... grant to support the clinical investigation of Toca 511 ... high grade glioma brain cancer (Grade 3 or Grade ... novel treatments for advanced cancer, with an initial focus ...
(Date:6/19/2013)... BETHESDA, Md. , June 19, 2013 /PRNewswire/ -- ... "Company"), an American healthcare company providing services in ... of United Family Healthcare, a network of private ... official opening of its Beijing United Family Rehabilitation ... development projects of the United Family Healthcare ("UFH") ...
(Date:6/19/2013)... -- BD Biosciences, a segment of BD (Becton, Dickinson and ... technology company, today announced the launch of the BD ... of high-performance research flow cytometers. The BD ... most compact footprint in its class at just 30" x ... (76.2 cm). Recognizing that space is a valuable commodity in ...
Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2
(Date:6/19/2013)... In what is believed to be the largest follow-up ... hereditary dystonia a movement disorder that can cause ... report good success rates and lasting benefits. , Michele ... at Cedars-Sinai Medical Center,s Department of Neurology, and Ron ... at Beth Israel Deaconess Medical Center in Boston, published ...
(Date:6/19/2013)... Arbor, Mich. Children had half as many ... evening office hours on five or more days a ... at C.S. Mott Children,s Hospital and Johns Hopkins University. ... in The Journal of Pediatrics and will ... "These findings are an important step in understanding where ...
(Date:6/19/2013)... no-strings sexual encounters are increasingly common on college ... others to "hook up"? A new study by ... and Preventive Medicine, published online by the ... certain factors and behaviors associated with sexual hookups, ... the potential for negative emotional and physical health ...
(Date:6/19/2013)... for repairing damage to the genetic material DNA become ... seem, those compounds are sparking optimism as potential treatments ... in BRCA, a gene that made headlines when actress ... termed PARP inhibitors, are the topic of the cover ... Engineering News . C&EN is the weekly news magazine ...
(Date:6/19/2013)... Center and colleagues at Louisiana State University have developed ... immediate therapy. It relies on understanding the genetic interaction ... better predict a prostate cancer,s aggressiveness to avoid unnecessary ... the online journal PLOS ONE in April. ... 20 percent of all cancers and 9 percent of ...
Breaking Medicine News(10 mins):Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2
... investigators say , MONDAY, July 6 (HealthDay News) -- ... that help breast cancer cells survive in the bone marrow ... the July issue of the journal Cancer Cell , ... according to the researchers. , "We sought to identify signaling ...
... study suggests, , MONDAY, July 6 (HealthDay News) -- Children ... diabetes, rheumatoid arthritis and celiac disease have up to ... finds. , Although the association between autism and a maternal ... found in earlier research, the researchers behind the new study ...
... Every year as many as seven million adults in ... systematic review of the scientific literature on delirium prevention ... the Regenstrief Institute and Wishard Health Services found that ... for hospitalized adults, no effective way to prevent or ...
... study to determine the non-medical factors that may be ... researchers at Columbia University Mailman School of Public Health ... of chemotherapy in elderly women with breast cancer and ... if treated by oncologists employed in a private practice. ...
... , IRVINE, Calif., July 6 Quest International, Inc. announced ... Healthcare,s Best Global Supplier of the Year Award. This ... presented with the award, receiving honors in 2006 as well. ... 2009 Siemens Annual Supplier Conference. Quest was selected for ...
... of one of the nation,s largest Medicare chronic condition special ... care for seniors with chronic illness, today announced the appointment ... effective August 1, 2009. , , Prior to ... CEO of United HealthCare,s Evercare healthplans, the business unit that ...
Cached Medicine News:Health News:Research Reveals Clues to Breast Cancer's Spread 2Health News:Autism May Be Linked to Mom's Autoimmune Disease 2Health News:Autism May Be Linked to Mom's Autoimmune Disease 3Health News:Autism May Be Linked to Mom's Autoimmune Disease 4Health News:Delirium in hospitalized adults: Situation critical, no relief available 2Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 2Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 3Health News:Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 2Health News:Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 3Health News:Dr. John Mach Appointed Chief Medical Officer at XLHealth 2
... HRR 4th edition pseudoisochromatic test from Richmond ... screener plates and the 14 diagnostic series for ... plates has its own tab for easy and ... set of instructions in English and a laminated ...
Ishihara test chart book for color blindness. 14 plate. A simple accurate method for discovering congenital color blindness....
Ishihara 14 plate color vision testing set. Suitable for screening purposes....
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Medicine Products: